Nkarta Inc Share Price Today: Live Updates & Key Insights

Nkarta Inc share price today is $2.19, up -1.38%. The stock opened at $2.175 against the previous close of $2.17, with an intraday high of $2.215 and low of $2.11.

Nkarta Inc Share Price Chart

Nkarta Inc

us-stock
To Invest in {{usstockname}}
us-stock

Nkarta Inc Share Price Performance

$2.19 -0.0138(-1.38%) NKTX at 23 Mar 2026 02:28 PM Biotechnology
Lowest Today 2.11
Highest Today 2.215
Today’s Open 2.175
Prev. Close 2.17
52 Week High 2.81
52 Week Low 1.31
Day’s Range: Low 2.11 High 2.215
52-Week Range: Low 1.31 High 2.81
1 day return -
1 Week return -5.9
1 month return -7.12
3 month return +19.77
6 month return +2.62
1 year return +39.15
3 year return -36.39
5 year return -94.94
10 year return -

Nkarta Inc Institutional Holdings

RA Capital Management, LLC 15.21

TANG CAPITAL MANAGEMENT LLC 9.93

BlackRock Inc 5.21

NEA Management Company, LLC 5.02

Samsara BioCapital, LLC 4.94

SR ONE CAPITAL MANAGEMENT, LP 4.69

Vanguard Group Inc 3.66

Alyeska Investment Group, L.P. 2.94

Monaco Asset Management 2.77

Renaissance Technologies Corp 2.40

Wasatch Advisors LP 2.22

Wasatch Ultra Growth 2.09

Vanguard Total Stock Mkt Idx Inv 1.99

Citadel Advisors Llc 1.89

Geode Capital Management, LLC 1.63

State Street Corp 1.62

JPMorgan Chase & Co 1.57

iShares Russell 2000 ETF 1.53

Two Sigma Investments LLC 1.37

Awm Investment Company Inc 1.28

Blackstone Inc 1.05

Peapod Lane Capital LLC 0.95

Two Sigma Advisers, LLC 0.91

JPM Thematics Genetic Thrps C2 dist USD 0.82

Vanguard Institutional Extnd Mkt Idx Tr 0.78

Fidelity Small Cap Index 0.60

State St Russell Sm/Mid Cp® Indx SL Cl I 0.51

iShares Russell 2000 Value ETF 0.51

Fidelity Extended Market Index 0.39

State St Russell Sm Cap® Indx SL Cl I 0.31

Vanguard Russell 2000 ETF 0.29

Invesco RAFI US 1500 Small-Mid ETF 0.20

A4Investments SICAV SIF ACCI IlanaA2EURH 0.17

Blackrock Extended Mkt Fund CF 0.17

iShares Micro-Cap ETF 0.16

Stt Strt SPDR® Russell2000 US SmCapETF 0.15

Schwab Small Cap Index 0.15

Vifag 2002 SICAV 0.15

Extended Equity Market Fund K 0.14

CREF Total Global Stock Account R3 0.13

Nkarta Inc Market Status

Strong Buy: 4

Buy: 2

Hold: 1

Sell: 0

Strong Sell: 0

Nkarta Inc Fundamentals

Market Cap 152.00 M

PB Ratio 0.4572

PE Ratio 0.0

Enterprise Value -51.56 M

Total Assets 501.20 M

Volume 903043

Nkarta Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:115385 0.1M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:115385 0.1M

Annual Net worth FY23:-122329000 -122.3M, FY22:-119425000 -119.4M, FY21:-83949000 -83.9M, FY20:-50409000 -50.4M, FY19:-22883898 -22.9M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-2331000 -2.3M, Q1/2025:-2299000 -2.3M, Q3/2024:null 0.0M, Q2/2024:-2262000 -2.3M

Quarterly Net worth Q3/2025:-21715000 -21.7M, Q2/2025:-22977000 -23.0M, Q1/2025:-31983000 -32.0M, Q3/2024:-28344000 -28.3M, Q2/2024:-24993000 -25.0M

About Nkarta Inc & investment objective

Company Information Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Organisation Biotechnology

Employees 105

Industry Biotechnology

CEO Mr. Paul J. Hastings

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Nkarta Inc FAQs

What is the share price of Nkarta Inc today?

The current share price of Nkarta Inc is $2.19.

Can I buy Nkarta Inc shares in India?

Yes, Indian investors can buy Nkarta Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Nkarta Inc shares in India?

You can easily invest in Nkarta Inc shares from India by:

Can I buy fractional shares of Nkarta Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Nkarta Inc?

Nkarta Inc has a market cap of $152.00 M.

In which sector does Nkarta Inc belong?

Nkarta Inc operates in the Biotechnology sector.

What documents are required to invest in Nkarta Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Nkarta Inc?

The PE ratio of Nkarta Inc is N/A and the PB ratio is 0.46.